January 2020

Letter from the Editor

January 1, 2020

The Road Ahead As we head into 2020, closing out a decade punctuated by an ever-changing healthcare dynamic shaped by scientific discoveries, technological breakthroughs, innovation at every level, as well as global geopolitical forces, there is no doubt that the status quo is no longer a business mantra. This month’s cover story is a perfect […]

Upfront

January 1, 2020

GSK Offers Grants to Nonprofits Making an IMPACT on Health Outcomes GlaxoSmithKline has honored 10 Philadelphia nonprofit organizations that offer youth mentoring, housing, legal aid, education, and other critical services that help foster a healthier region. The 10 winners of the GSK IMPACT Awards each will receive $40,000 to help further their efforts to improve […]

HealthTech

January 1, 2020

Astellas and Welldoc Pair Up for Digital Therapeutics Trend Watch: Pharma’s Use of Healthtech Continues to Gain Ground Astellas Pharma and Welldoc have entered into a collaboration and license agreement directed toward the development and commercialization of digital health solutions. Under the agreement, Astellas and Welldoc will jointly develop and commercialize a digital health solution […]

Artificial Intelligence

January 1, 2020

Cyclica and ATAI Partner to Develop Drugs to Treat Mental Health Trend Watch: Partnerships Leverage AI for Drug Discovery and Development Cyclica, an artificial intelligence-powered biotechnology company, has partnered with the biotech company ATAI Life Sciences to create Entheogenix Biosciences. Entheogenix Biosciences is aimed at advancing psychedelic research for the development of better medicines for […]

Innovator’s Corner

January 1, 2020

Fish Skin for Wounds Fertram Sigurjonsson, Founder and CEO of Kerecis, talks about his company’s skin-substitution technology, which comes from Icelandic cod. Fertram Sigurjonsson started Kerecis because he wanted to help people avoid life-altering amputations, which often result from hard-to-heal wounds. His inspiration for the technology came about from the work he had been doing […]

Last Word

January 1, 2020

Creating an Innovative Culture Fabrice Chouraqui, former president of Novartis Pharmaceuticals US, discusses his vision for creating an organization that is fueled by innovation. PV: How do you define innovation and what was your vision for reshaping of the pharmaceutical division of Novartis in the United States to become more innovation focused? Chouraqui: Innovation is […]

Small Pharma Driving Big Pharma Innovation

January 1, 2020

The Path to R&D Innovation Lies in the Power of Small Pharma Visionary thought leaders such as Bernard Munos of InnoThink and the Milken Institute and Paul Stoffels, M.D., vice chairman of the executive committee and chief scientific officer, Johnson & Johnson, have been advocating for years that the blockbuster model is broken and unsustainable. […]

SHOWCASE: High-Science Brands: Making Connections for High Science Brands

January 1, 2020

The growth of high-science brands has changed the life sciences landscape, and with it the strategies companies need to develop to market their products must also undergo a significant shift. Cancer immunotherapies as well as other high-science brands will account for $34 billion in sales by 2024, according to GlobalData. Furthermore, it’s been estimated that […]

High-Science Storytelling: Cracking the Code on Meaningful Messaging

January 1, 2020

In full transparency, I am a high-science geek. I am jazzed by data, by new technologies and pathways, but most importantly, I am particularly motivated when I have the ability to work on clinically meaningful advancements that truly make a difference in patients’ lives. I am the one in the crowd who readily raises my […]

Facts Tell, Stories Sell

January 1, 2020

People hear facts, but feel stories, and medical storytelling today is a winning combination of both. In 2013, Novartis broke the mold in marketing with its campaign for its oral multiple sclerosis treatment Gilenya. The campaign, “Hey MS, Take This!” shows various patients sticking out their tongues with Gilenya capsules on them. Novartis reported that […]

SHOWCASE: Virtual Health: Exploring the Potential of Virtual Health

January 1, 2020

As healthcare costs continue to spiral, the need to find effective ways to balance the demands of an aging population becomes more pressing. One approach that has the potential to make a significant difference is virtual health, which allows patients with chronic diseases to be monitored more efficiently without needing to hire more clinicians. According […]

What Do Patients Want From Virtual Trials?

January 1, 2020

How to plan for a successful patient-centric virtual trial Virtual and hybrid clinical trials, which require few or no visits to a trial site, have arrived as part of the new frontier of innovative, patient-centric research models. Through telemedicine, online patient portals, and connected devices, sponsors bring the trial directly to the patient so it’s […]

Wear it on Your Sleeve — How Sensors and Wearables Help Drive Richer Insights on Intervention Effects

January 1, 2020

“I didn’t sleep well last night.” It’s a phrase we’ve all heard, and unfortunately said, hundreds if not thousands of times. For some of us, the phrase instantly invokes the struggles to fall asleep, tossing and turning throughout the night. For others it means constantly waking up, gaining only an hour or two here or […]

RNAi: Advancing the Field of Biology

January 1, 2020

RNAi therapeutics, a new class of medicines, enable specific and highly effective gene silencing. RNA interference, also known as RNAi, is a breakthrough in understanding how genes are regulated in cells. RNAi has the potential to change the landscape of medicine and represents a new approach to drug discovery and development. Biopharma companies are harnessing […]

Unraveling Data Ownership

January 1, 2020

Amid ongoing concerns over data privacy and how patients’ data is used, who owns the data is both a crucial and complex question. Just who owns a patient’s data? It’s a question that is fraught with complications due to the sensitive nature of the information. Data has been described as the most valuable currency for […]

Commanders & Chiefs: Biotech

January 1, 2020

Biotech and biopharma executives provide their insights on what the future holds for their sector of the industry. What should we expect to see from the biotech/biopharma industry in the coming decade? Coloma. We will see transformative-level improvement in the way we discover, develop, and commercialize drugs as a response to the changing reimbursement landscape […]

FEEDBACK